anti-CD4 CAR T cells
Term · Oncology and biomedicine · MLC-T-ONC-010386
A preparation of T lymphocytes that have been genetically modified and transduced with a lentiviral vector expressing a chimeric antigen receptor (CAR) targeting the tumor-associated antigen (TAA) CD4 and containing, as of yet undisclosed co-stimulatory signaling domains, with potential immunostimulating and antineoplastic activities. Upon administration, anti-CD4 CAR T cells target and bind to CD4-expressing tumor cells, thereby inducing selective toxicity in CD4-expressing tumor cells. CD4 antigen is expressed in CD4-positive T cell lymphomas.
| Identifier | MLC-T-ONC-010386 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | CD4 CAR T cells; CD4-specific CAR T cells |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010386",
"term": "anti-CD4 CAR T cells",
"field": "Oncology and biomedicine",
"definition": "A preparation of T lymphocytes that have been genetically modified and transduced with a lentiviral vector expressing a chimeric antigen receptor (CAR) targeting the tumor-associated antigen (TAA) CD4 and containing, as of yet undisclosed co-stimulatory signaling domains, with potential immunostimulating and antineoplastic activities. Upon administration, anti-CD4 CAR T cells target and bind to CD4-expressing tumor cells, thereby inducing selective toxicity in CD4-expressing tumor cells. CD4 antigen is expressed in CD4-positive T cell lymphomas.",
"synonyms": [
"CD4 CAR T cells",
"CD4-specific CAR T cells"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/anti-cd4-car-t-cells/"
}
Record 1,474 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.